Related Experiment Video
Updated: Jul 8, 2026
06:21
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Regional brain activation during hypoglycemia in type 1 diabetes
Gail Musen1, Donald C Simonson, Nicolas R Bolo
1Research Division, Joslin Diabetes Center, 1 Joslin Place Room 350, Boston, Massachusetts 02215, USA. gail.musen@joslin.harvard.edu
The Journal of Clinical Endocrinology and Metabolism
|January 17, 2008
Summary
The brain activates specific regions, including the hypothalamus, during hypoglycemia. This study identified the glucose levels triggering this response in both healthy individuals and type 1 diabetic patients.
Area of Science:
- Neuroscience
- Endocrinology
- Medical Imaging
Background:
- Brain response mechanisms to hypoglycemia remain poorly understood.
- Identifying these mechanisms is crucial for managing metabolic disorders and neurological function.
Purpose of the Study:
- To determine the specific blood glucose levels that activate the hypothalamus and other brain regions during hypoglycemia.
- To compare these activation thresholds between individuals with type 1 diabetes and healthy control subjects.
Main Methods:
- Cross-sectional study utilizing functional magnetic resonance imaging (fMRI).
- Hyperinsulinemic hypoglycemic clamp technique to induce controlled hypoglycemia.
- Inclusion of seven type 1 diabetic patients and six matched control subjects.
Main Results:
- Hypothalamic activation occurred at 68 ± 9 mg/dl in controls and 76 ± 8 mg/dl in diabetic patients.
- Common activation in brainstem, anterior cingulate cortex, uncus, and putamen (P < 0.001) in both groups.
- Distinct brain regions were uniquely activated within each group.
Conclusions:
- fMRI effectively identifies glucose thresholds for hypothalamic activation during hypoglycemia.
- A core network of brain regions is consistently activated during hypoglycemia in both diabetic and control populations.
- Potential differences in activation thresholds warrant further investigation across patient groups.
Related Concept Videos
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.